Suven Life Sciences Ltd Competitors & Peer Comparison
Pharmaceuticals · Indian listed companies
Compare Suven Life Sciences Ltd with 125 companies shown from the same industry classification, including Aarti Pharmalabs Ltd, Procter & Gamble Health Ltd, Morepen Laboratories Ltd. These are industry peers; their products, customers and business models may differ.
Selected-company price and ratio data: . Peer reporting dates can differ. Stored figures, not live quotes.
Compare valuation, size and returns
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Suven Life Sciences Ltd | 8,124 Cr. | 288 | 403/124 | 22.4 | 0.00 % | 79.5 % | 81.5 % | 1.00 | |
| Aarti Pharmalabs Ltd | 7,975 Cr. | 880 | 1,002/584 | 37.0 | 234 | 0.38 % | 10.7 % | 8.59 % | 5.00 |
| Procter & Gamble Health Ltd | 8,574 Cr. | 5,166 | 6,975/4,700 | 25.7 | 316 | 2.99 % | 83.9 % | 61.9 % | 10.0 |
| Morepen Laboratories Ltd | 7,485 Cr. | 137 | 151/33.0 | 63.8 | 22.8 | 0.14 % | 8.05 % | 5.33 % | 2.00 |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Entero Healthcare Solutions Ltd | 7,349 Cr. | 1,689 | 1,920/944 | 57.0 | 388 | 0.00 % | 10.5 % | 6.94 % | 10.0 |
| Bliss GVS Pharma Ltd | 7,247 Cr. | 682 | 745/118 | 52.7 | 113 | 0.22 % | 16.9 % | 11.8 % | 1.00 |
| Sanofi India Ltd | 6,864 Cr. | 2,982 | 4,898/2,967 | 20.0 | 359 | 2.52 % | 57.5 % | 43.0 % | 10.0 |
| IOL Chemicals & Pharmaceuticals Ltd | 6,464 Cr. | 220 | 224/67.1 | 36.6 | 61.3 | 0.45 % | 11.3 % | 8.42 % | 2.00 |
| Blue Jet Healthcare Ltd | 9,824 Cr. | 519 | 693/325 | 41.8 | 78.4 | 0.23 % | 26.1 % | 19.4 % | 2.00 |
| Orchid Pharma Ltd | 5,876 Cr. | 981 | 1,144/471 | 325 | 300 | 0.00 % | 1.86 % | 1.49 % | 10.0 |
| FDC Ltd | 5,349 Cr. | 329 | 474/313 | 17.4 | 153 | 1.52 % | 15.4 % | 11.2 % | 1.00 |
| Gujarat Themis Biosyn Ltd | 4,812 Cr. | 370 | 479/225 | 98.9 | 26.4 | 0.18 % | 18.1 % | 17.4 % | 1.00 |
| RPG Life Sciences Ltd | 4,665 Cr. | 2,821 | 3,130/1,731 | 40.0 | 366 | 0.82 % | 25.7 % | 19.3 % | 8.00 |
| Zota Health Care Ltd | 4,580 Cr. | 1,322 | 1,740/1,022 | 200 | 0.08 % | 8.47 % | 15.0 % | 10.0 | |
| Gufic BioSciences Ltd | 4,237 Cr. | 423 | 468/268 | 57.6 | 66.2 | 0.02 % | 12.2 % | 9.98 % | 1.00 |
| SMS Pharmaceuticals Ltd | 4,203 Cr. | 449 | 494/264 | 46.4 | 85.9 | 0.09 % | 12.9 % | 11.9 % | 1.00 |
| Aarti Drugs Limited | 3,811 Cr. | 418 | 534/319 | 22.0 | 154 | 0.48 % | 11.7 % | 12.7 % | 10.0 |
| Unichem Laboratories Ltd | 3,744 Cr. | 531 | 687/278 | 30.6 | 386 | 0.00 % | 4.13 % | 3.17 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 3,663 Cr. | 3,530 | 3,949/829 | 44.8 | 321 | 0.00 % | 23.9 % | 22.5 % | 10.0 |
| Ind-Swift Laboratories Ltd | 3,401 Cr. | 391 | 425/87.0 | 52.3 | 159 | 0.00 % | 4.86 % | 4.02 % | 10.0 |
| Solara Active Pharma Sciences Ltd | 3,185 Cr. | 656 | 774/422 | 746 | 346 | 0.00 % | 4.86 % | 0.13 % | 10.0 |
| Advanced Enzyme Technologies Ltd | 3,024 Cr. | 270 | 420/252 | 19.2 | 146 | 1.98 % | 14.0 % | 10.2 % | 2.00 |
| Hikal Ltd | 2,777 Cr. | 225 | 261/146 | 65.5 | 97.2 | 0.27 % | 3.50 % | 2.21 % | 2.00 |
| Fredun Pharmaceuticals Ltd | 2,529 Cr. | 1,532 | 1,666/454 | 56.9 | 170 | 0.02 % | 21.5 % | 15.8 % | 10.0 |
| Dishman Carbogen Amcis Ltd | 2,390 Cr. | 152 | 306/128 | 132 | 426 | 0.00 % | 3.14 % | 1.58 % | 2.00 |
| Concord Biotech Ltd | 13,948 Cr. | 1,331 | 1,627/987 | 49.0 | 193 | 0.57 % | 17.4 % | 12.6 % | 1.00 |
| Venus Remedies Ltd | 2,292 Cr. | 1,681 | 2,044/432 | 19.7 | 497 | 0.59 % | 20.7 % | 15.6 % | 10.0 |
| Indoco Remedies Ltd | 2,276 Cr. | 247 | 317/162 | 102 | 0.08 % | 0.96 % | 9.36 % | 2.00 | |
| Marksans Pharma Ltd | 13,976 Cr. | 308 | 351/155 | 27.0 | 66.7 | 0.28 % | 18.8 % | 15.2 % | 1.00 |
| Syncom Formulations (India) Ltd | 2,217 Cr. | 23.6 | 27.5/10.2 | 26.2 | 4.39 | 0.42 % | 24.8 % | 17.6 % | 1.00 |
| Beta Drugs Ltd | 2,208 Cr. | 1,991 | 2,808/990 | 48.4 | 241 | 0.00 % | 19.2 % | 18.8 % | 10.0 |
| Panacea Biotec Ltd | 2,124 Cr. | 347 | 648/292 | 136 | 0.00 % | 2.43 % | 2.42 % | 1.00 | |
| Hester Biosciences Ltd | 1,844 Cr. | 2,167 | 2,684/1,239 | 34.7 | 423 | 0.51 % | 15.2 % | 15.9 % | 10.0 |
| Fermenta Biotech Ltd | 1,587 Cr. | 540 | 583/249 | 29.0 | 138 | 0.69 % | 20.6 % | 16.4 % | 5.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,553 Cr. | 235 | 265/155 | 33.0 | 41.2 | 1.70 % | 22.7 % | 17.3 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,508 Cr. | 522 | 760/476 | 24.2 | 128 | 0.94 % | 24.8 % | 18.4 % | 1.00 |
| Astrazeneca Pharma India Ltd | 14,795 Cr. | 5,918 | 9,850/5,802 | 85.3 | 349 | 0.61 % | 29.3 % | 23.3 % | 2.00 |
| TTK Healthcare Ltd | 1,423 Cr. | 1,007 | 1,250/735 | 18.6 | 789 | 0.99 % | 8.04 % | 6.30 % | 10.0 |
| Kopran Ltd | 1,237 Cr. | 256 | 296/107 | 49.5 | 110 | 1.17 % | 6.65 % | 4.91 % | 10.0 |
| Lincoln Pharmaceuticals Ltd | 1,121 Cr. | 560 | 770/440 | 11.6 | 378 | 0.32 % | 16.3 % | 12.3 % | 10.0 |
| Themis Medicare Ltd | 1,003 Cr. | 109 | 147/65.0 | 43.3 | 0.46 % | 2.74 % | 0.41 % | 1.00 | |
| Bafna Pharmaceuticals Ltd | 951 Cr. | 402 | 409/94.8 | 122 | 40.6 | 0.00 % | 11.9 % | 12.3 % | 10.0 |
| Kilitch Drugs (India) Ltd | 845 Cr. | 242 | 268/117 | 28.1 | 80.0 | 0.00 % | 13.4 % | 10.6 % | 10.0 |
| Anuh Pharma Ltd | 820 Cr. | 81.6 | 99.5/66.7 | 18.6 | 35.1 | 1.83 % | 14.9 % | 10.7 % | 5.00 |
| Jubilant Pharmova Ltd | 15,525 Cr. | 975 | 1,185/784 | 40.0 | 445 | 0.51 % | 8.99 % | 6.53 % | 1.00 |
| Wanbury Ltd | 679 Cr. | 194 | 360/162 | 15.8 | 18.1 | 0.00 % | 36.6 % | 76.5 % | 10.0 |
| Natco Pharma Ltd | 15,615 Cr. | 796 | 1,217/786 | 13.8 | 470 | 0.62 % | 17.4 % | 17.1 % | 2.00 |
| Albert David Ltd | 464 Cr. | 813 | 932/580 | 20.6 | 686 | 0.62 % | 0.82 % | 0.44 % | 10.0 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| ERIS Lifesciences Ltd | 15,897 Cr. | 1,146 | 1,740/1,141 | 24.2 | 282 | 0.63 % | 14.1 % | 18.7 % | 1.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 330 Cr. | 102 | 110/50.3 | 79.0 | 53.0 | 0.00 % | 5.58 % | 2.75 % | 10.0 |
| BDH Industries Ltd | 274 Cr. | 475 | 610/340 | 23.4 | 134 | 1.05 % | 20.5 % | 14.8 % | 10.0 |
| Lyka Labs Ltd | 262 Cr. | 72.5 | 105/44.1 | 25.9 | 0.00 % | 5.98 % | 10.2 % | 10.0 | |
| Everest Organics Ltd | 241 Cr. | 242 | 536/197 | 45.9 | 77.7 | 0.00 % | 12.0 % | 7.63 % | 10.0 |
| Gennex Laboratories Ltd | 237 Cr. | 9.77 | 17.2/7.05 | 12.6 | 9.16 | 0.00 % | 11.8 % | 10.5 % | 1.00 |
| Nectar Lifescience Ltd | 204 Cr. | 10.5 | 22.5/9.20 | 30.0 | 0.00 % | 0.05 % | 31.3 % | 1.00 | |
| Ambalal Sarabhai Enterprises Ltd | 203 Cr. | 26.5 | 42.0/23.1 | 11.4 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Coral Laboratories Ltd | 193 Cr. | 540 | 679/360 | 10.2 | 585 | 0.37 % | 11.0 % | 7.79 % | 10.0 |
| Brooks Laboratories Ltd | 173 Cr. | 58.8 | 132/36.3 | 13.1 | 41.6 | 0.00 % | 21.2 % | 22.0 % | 10.0 |
| Bal Pharma Ltd | 157 Cr. | 98.6 | 125/59.7 | 21.8 | 51.6 | 1.22 % | 9.75 % | 7.79 % | 10.0 |
| Par Drugs & Chemicals Ltd | 149 Cr. | 121 | 180/78.0 | 10.3 | 91.0 | 0.00 % | 14.6 % | 9.95 % | 10.0 |
| Auro Laboratories Ltd | 147 Cr. | 236 | 317/159 | 30.8 | 74.4 | 0.00 % | 9.52 % | 8.49 % | 10.0 |
| Godavari Drugs Ltd | 141 Cr. | 129 | 135/69.7 | 36.2 | 74.8 | 0.00 % | 6.55 % | 6.14 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 139 Cr. | 9.49 | 14.3/1.96 | 46.3 | 0.81 | 0.00 % | 22.9 % | 16.6 % | 1.00 |
| Lactose (India) Ltd | 135 Cr. | 107 | 136/76.0 | 19.4 | 51.5 | 0.00 % | 11.3 % | 9.81 % | 10.0 |
| Achyut Healthcare Ltd | 132 Cr. | 5.47 | 10.0/4.70 | 413 | 1.45 | 0.00 % | 1.18 % | 0.96 % | 1.00 |
| Krebs Biochemicals & Industries Ltd | 125 Cr. | 57.8 | 76.8/38.3 | 75.5 | 0.00 % | 15.4 % | % | 10.0 | |
| Alpa Laboratories Ltd | 121 Cr. | 57.7 | 99.8/46.0 | 27.8 | 93.4 | 0.00 % | 8.91 % | 7.90 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 108 Cr. | 30.5 | 53.9/25.6 | 13.5 | 0.00 % | 18.5 % | 26.5 % | 10.0 | |
| Vaishali Pharma Ltd | 104 Cr. | 7.99 | 11.5/4.75 | 24.6 | 5.29 | 0.00 % | 8.93 % | 6.02 % | 2.00 |
| Concord Drugs Ltd | 93.5 Cr. | 71.0 | 92.5/61.0 | 45.8 | 36.8 | 0.00 % | 5.19 % | 2.52 % | 10.0 |
| Denis Chem Lab Ltd | 90.7 Cr. | 65.4 | 94.6/56.1 | 11.4 | 66.0 | 3.83 % | 14.0 % | 9.52 % | 10.0 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | / | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Fervent Synergies Ltd | 74.4 Cr. | 14.9 | 26.0/13.0 | 20.4 | 11.4 | 0.00 % | 7.21 % | 7.22 % | 10.0 |
| Cian Healthcare Ltd | 63.6 Cr. | 25.4 | 25.4/4.72 | 3.42 | 0.00 % | 15.1 % | 49.2 % | 10.0 | |
| Vivimed Labs Ltd | 58.3 Cr. | 6.91 | 29.4/4.75 | 25.4 | 0.00 % | 65.2 % | % | 2.00 | |
| Mangalam Drugs and Organics Ltd | 49.8 Cr. | 31.5 | 74.0/22.7 | 65.3 | 0.00 % | 14.0 % | 34.8 % | 10.0 | |
| Biofil Chemicals & Pharmaceuticals Ltd | 49.5 Cr. | 30.4 | 46.8/25.6 | 103 | 13.2 | 0.00 % | 2.97 % | 2.83 % | 10.0 |
| ANG Lifesciences India Ltd | 48.4 Cr. | 37.1 | 49.7/17.6 | 47.6 | 0.00 % | 1.14 % | 7.38 % | 10.0 | |
| Murae Organisor Ltd | 38.8 Cr. | 0.19 | 0.44/0.19 | 2.56 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Bharat Immunological & Biological Corporation Ltd | 38.2 Cr. | 8.84 | 22.6/7.11 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
| Bacil Pharma Ltd | 34.8 Cr. | 24.2 | 61.8/10.6 | 53.5 | 17.3 | 0.00 % | 3.93 % | 6.21 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 28.8 Cr. | 38.2 | 53.0/29.7 | 9.45 | 43.9 | 0.00 % | 12.1 % | 9.67 % | 10.0 |
| Gujarat Terce Laboratories Ltd | 27.6 Cr. | 35.4 | 59.8/29.0 | 12.4 | 12.5 | 0.00 % | 39.2 % | 30.2 % | 10.0 |
| Colinz Laboratories Ltd | 18.5 Cr. | 73.5 | 87.9/36.1 | 37.0 | 39.9 | 0.00 % | 7.20 % | 5.23 % | 10.0 |
| Checkpoint Trends Ltd | 17.3 Cr. | 31.6 | 144/28.4 | 14.1 | 42.5 | 0.00 % | 15.0 % | 12.7 % | 10.0 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
| Desh Rakshak Aushdhalaya Ltd | 15.3 Cr. | 26.9 | 59.6/22.4 | 27.9 | 23.3 | 0.00 % | 7.50 % | 5.59 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 13.6 Cr. | 91.0 | 153/70.0 | 8.60 | 0.00 % | 0.28 % | 0.28 % | 10.0 | |
| Beryl Drugs Ltd | 12.8 Cr. | 25.2 | 27.6/15.9 | 20.7 | 19.5 | 0.00 % | 7.25 % | 4.34 % | 10.0 |
| Dipna Pharmachem Ltd | 10.2 Cr. | 3.89 | 25.0/3.89 | 3.89 | 23.7 | 0.00 % | 7.64 % | 5.22 % | 10.0 |
| Adline Chem Lab Ltd | 9.24 Cr. | 15.8 | 16.2/7.60 | 3.03 | 0.00 % | 1,267 % | % | 10.0 | |
| Brawn Biotech Ltd | 7.62 Cr. | 25.4 | 25.7/17.7 | 8.96 | 14.5 | 0.00 % | 0.00 % | 24.4 % | 10.0 |
| Ganga Pharmaceuticals Ltd | 7.39 Cr. | 12.5 | 14.0/9.35 | 73.9 | 14.1 | 0.00 % | 2.90 % | 1.30 % | 10.0 |
| Decipher Labs Ltd | 5.75 Cr. | 5.69 | 11.0/5.00 | 20.5 | 0.00 % | 16.7 % | 14.2 % | 10.0 | |
| Amerise Biosciences Ltd | 5.22 Cr. | 0.79 | 1.03/0.50 | 0.82 | 0.00 % | 0.37 % | 0.37 % | 1.00 | |
| Fabino Enterprises Ltd | 4.27 Cr. | 20.3 | 27.0/13.0 | 18.7 | 0.00 % | 6.22 % | 8.76 % | 10.0 | |
| Evoq Remedies Ltd | 4.08 Cr. | 1.64 | 6.11/1.35 | 17.8 | 0.00 % | 0.56 % | 0.54 % | 10.0 | |
| MPS Pharmaa Ltd | 3.98 Cr. | 2.08 | 2.08/1.57 | 0.04 | 0.00 % | 13.1 % | 177 % | 10.0 | |
| Alembic Pharmaceuticals Ltd | 16,389 Cr. | 834 | 998/635 | 22.0 | 289 | 1.44 % | 12.6 % | 13.4 % | 2.00 |
| Cohance Lifesciences Ltd | 16,932 Cr. | 443 | 918/267 | 157 | 102 | 0.00 % | 5.81 % | 4.89 % | 1.00 |
| Pfizer Ltd | 17,073 Cr. | 3,732 | 5,578/3,732 | 22.2 | 919 | 1.96 % | 24.1 % | 18.0 % | 10.0 |
| Caplin Point Laboratories Ltd | 20,136 Cr. | 2,649 | 2,991/1,500 | 30.3 | 443 | 0.30 % | 24.2 % | 20.9 % | 2.00 |
| Shilpa Medicare Ltd | 20,145 Cr. | 1,030 | 1,096/260 | 70.9 | 132 | 0.06 % | 10.9 % | 8.99 % | 1.00 |
| Granules India Ltd | 23,058 Cr. | 845 | 924/520 | 35.5 | 205 | 0.21 % | 15.5 % | 13.8 % | 1.00 |
| Acutaas Chemicals Ltd | 25,039 Cr. | 3,057 | 3,740/1,380 | 64.8 | 202 | 0.08 % | 31.6 % | 24.0 % | 5.00 |
| Neuland Laboratories Ltd | 26,987 Cr. | 21,034 | 24,235/11,500 | 54.3 | 1,461 | 0.16 % | 26.5 % | 21.2 % | 10.0 |
| Wockhardt Ltd | 33,005 Cr. | 2,030 | 2,422/1,087 | 82.8 | 304 | 0.00 % | 7.55 % | 6.11 % | 5.00 |
| J B Chemicals & Pharmaceuticals Ltd | 38,677 Cr. | 2,409 | 2,526/1,642 | 53.8 | 259 | 0.91 % | 25.4 % | 18.9 % | 1.00 |
| Ajanta Pharma Ltd | 44,608 Cr. | 3,570 | 3,797/2,380 | 39.3 | 362 | 0.90 % | 34.5 % | 27.1 % | 2.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 44,622 Cr. | 2,634 | 3,121/2,088 | 42.4 | 134 | 2.16 % | 61.4 % | 45.6 % | 10.0 |
| Ipca Laboratories Ltd | 49,181 Cr. | 1,938 | 2,039/1,252 | 35.8 | 318 | 0.31 % | 17.0 % | 15.7 % | 1.00 |
| Gland Pharma Ltd | 51,988 Cr. | 3,151 | 3,171/1,574 | 36.8 | 656 | 0.63 % | 17.4 % | 12.8 % | 1.00 |
| Abbott India Ltd | 54,310 Cr. | 25,550 | 30,655/25,135 | 33.6 | 2,247 | 2.05 % | 44.8 % | 34.4 % | 10.0 |
| Biocon Ltd | 58,669 Cr. | 360 | 447/338 | 80.7 | 210 | 0.14 % | 3.61 % | 1.40 % | 5.00 |
| Glenmark Life Sciences Ltd | 62,243 Cr. | 2,210 | 2,538/1,793 | 20.0 | 372 | 0.23 % | 39.8 % | 23.6 % | 1.00 |
| Alkem Laboratories Ltd | 63,973 Cr. | 5,350 | 5,934/5,051 | 28.2 | 1,156 | 0.99 % | 21.2 % | 18.9 % | 2.00 |
| Glenmark Pharmaceuticals Ltd | 64,412 Cr. | 2,282 | 2,538/1,793 | 20.6 | 372 | 0.22 % | 39.8 % | 23.6 % | 1.00 |
| Lupin Ltd | 88,806 Cr. | 1,942 | 2,530/1,900 | 14.9 | 491 | 0.89 % | 29.9 % | 28.7 % | 2.00 |
| Aurobindo Pharma Ltd | 94,309 Cr. | 1,642 | 1,740/1,075 | 24.9 | 652 | 0.24 % | 12.9 % | 10.1 % | 1.00 |
| Mankind Pharma Ltd | 98,508 Cr. | 2,380 | 2,642/1,910 | 43.6 | 397 | 0.04 % | 13.7 % | 13.8 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,00,479 Cr. | 1,204 | 1,415/1,080 | 31.2 | 454 | 0.66 % | 13.0 % | 11.2 % | 1.00 |
| Cipla Ltd | 1,07,221 Cr. | 1,327 | 1,673/1,166 | 30.0 | 426 | 0.98 % | 15.5 % | 11.6 % | 2.00 |
| Laurus Labs Ltd | 1,08,062 Cr. | 2,000 | 2,065/843 | 124 | 97.3 | 0.10 % | 16.0 % | 15.2 % | 2.00 |
| Torrent Pharmaceuticals Ltd | 1,75,851 Cr. | 4,617 | 5,250/3,480 | 78.8 | 248 | 0.82 % | 15.2 % | 27.4 % | 5.00 |
| Industry Average | 17,219.37 Cr | 1,223.50 | 53.77 | 211.24 | 0.39% | 26.16% | 16.59% | 6.06 |
How to use this peer comparison
Start with similar company sizes, then compare P/E with ROCE and ROE. A lower P/E alone does not establish better value. Negative earnings, unusual items, debt and different reporting dates can make ratios unsuitable for direct comparison.
The company list is ordered by market-cap proximity to Suven Life Sciences Ltd, with P/E as a secondary comparison. The industry-average row uses available stored values across the industry, which can include companies beyond the rows shown. Missing values are not zero.
Open each company report for financial statements and its cited sources. Industry classifications indicate a research peer group, not a verified list of direct commercial competitors.
Read the full Suven Life Sciences Ltd analysis · Explore all Pharmaceuticals stocks